Lok, B. H., Gardner, E. E., Schneeberger, V. E., Ni, A., Desmeules, P., Rekhtman, N., . . . Rudin, C. M. (2016). PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer. Clin Cancer Res.
Citação norma ChicagoLok, Benjamin H., et al. "PARP Inhibitor Activity Correlates With SLFN11 Expression and Demonstrates Synergy With Temozolomide in Small Cell Lung Cancer." Clin Cancer Res 2016.
Citação norma MLALok, Benjamin H., et al. "PARP Inhibitor Activity Correlates With SLFN11 Expression and Demonstrates Synergy With Temozolomide in Small Cell Lung Cancer." Clin Cancer Res 2016.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.